Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin

  1. Usategui-Martín, R.
  2. Vega, G.
  3. Abad-Manteca, L.
  4. Ruiz-Mambrilla, M.
  5. Calero-Paniagua, I.
  6. Dueñas-Laita, A.
  7. Pérez-Castrillón, J.L.
Aldizkaria:
Basic and Clinical Pharmacology and Toxicology

ISSN: 1742-7843,  1742-7835

Argitalpen urtea: 2018

Alea: 123

Zenbakia: 6

Orrialdeak: 766-769

Mota: Artikulua

DOI: 10.1111/BCPT.13086 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak